.png){kind=icon}
返回
A
Amit Patel
University of Virginia Health System
19H指数
105论文数
1.5K被引数
收录论文 16
发表时间
.png){kind=icon}
Absence of CMR ischemia effectively rules out left main, multivessel disease, and serious cardiovascular events in a multicentric United States cohort of 4149 patients-long term follow-up of the SCMR SPINS registry (vol 27 , 101311, 2025)无CMR缺血可有效地排除左主干病变、多支血管病变和严重心血管事件，在一项多中心美国队列的4149例患者中——SCMR SPINS注册研究（卷27，101311，2025）的长期随访结果.png)
OAAI
.png){kind=icon}
OAAI.png){kind=icon}
分享.png){kind=icon}
收藏HEALTH-RELATED QUALITY OF LIFE (HRQOL) AND OTHER SECONDARY CLINICAL OUTCOMES IN ADULTS WITH GOUT REFRACTORYTO CONVENTIONALTHERAPYTREATED WITH SEL212: POOLED 6-MONTH DATA FROM THE PHASE 3 DISSOLVE I & II CLINICAL TRIALS与健康相关的生活质量（HRQOL）及其他次要临床结局指标：在难治性痛风成人患者中使用SEL212治疗的数据汇总——来自III期DISSOLVE I & II临床试验的6个月数据
PREAI
分享收藏LONG-TERM IMPROVEMENTS IN SERUM URIC ACID LEVELS, GOUT SYMPTOMS, AND SAFETY UPTO 12-MONTHS WITH SEL-212 IN GOUT REFRACTORY TO CONVENTIONAL THERAPY: RESULTS FROM THE DISSOLVE I PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL使用SEL-212治疗对常规疗法无效的痛风患者，在12个月内血清尿酸水平、痛风症状及安全性方面的长期改善：来自DISSOLVE I期3、双盲、安慰剂对照临床试验的结果
PREAI
分享收藏